269 related articles for article (PubMed ID: 28378188)
1. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells.
Perrott KM; Wiley CD; Desprez PY; Campisi J
Geroscience; 2017 Apr; 39(2):161-173. PubMed ID: 28378188
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids suppress selected components of the senescence-associated secretory phenotype.
Laberge RM; Zhou L; Sarantos MR; Rodier F; Freund A; de Keizer PL; Liu S; Demaria M; Cong YS; Kapahi P; Desprez PY; Hughes RE; Campisi J
Aging Cell; 2012 Aug; 11(4):569-78. PubMed ID: 22404905
[TBL] [Abstract][Full Text] [Related]
3. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network.
Orjalo AV; Bhaumik D; Gengler BK; Scott GK; Campisi J
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17031-6. PubMed ID: 19805069
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype.
Hou J; Cui C; Kim S; Sung C; Choi C
Chem Biol Interact; 2018 Mar; 283():75-83. PubMed ID: 29412148
[TBL] [Abstract][Full Text] [Related]
5. Effects of flavonoids on senescence-associated secretory phenotype formation from bleomycin-induced senescence in BJ fibroblasts.
Lim H; Park H; Kim HP
Biochem Pharmacol; 2015 Aug; 96(4):337-48. PubMed ID: 26093063
[TBL] [Abstract][Full Text] [Related]
6. S100A13 promotes senescence-associated secretory phenotype and cellular senescence via modulation of non-classical secretion of IL-1α.
Su Y; Xu C; Sun Z; Liang Y; Li G; Tong T; Chen J
Aging (Albany NY); 2019 Jan; 11(2):549-572. PubMed ID: 30670674
[TBL] [Abstract][Full Text] [Related]
7. Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells.
Yasuda S; Horinaka M; Iizumi Y; Goi W; Sukeno M; Sakai T
Biochem Biophys Res Commun; 2022 Jan; 590():55-62. PubMed ID: 34971958
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
[TBL] [Abstract][Full Text] [Related]
9. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.
Laberge RM; Sun Y; Orjalo AV; Patil CK; Freund A; Zhou L; Curran SC; Davalos AR; Wilson-Edell KA; Liu S; Limbad C; Demaria M; Li P; Hubbard GB; Ikeno Y; Javors M; Desprez PY; Benz CC; Kapahi P; Nelson PS; Campisi J
Nat Cell Biol; 2015 Aug; 17(8):1049-61. PubMed ID: 26147250
[TBL] [Abstract][Full Text] [Related]
10. Role of Clusterin/NF-κB in the secretion of senescence-associated secretory phenotype in Cr(VI)-induced premature senescent L-02 hepatocytes.
Liang Y; Liang N; Ma Y; Tang S; Ye S; Xiao F
Ecotoxicol Environ Saf; 2021 Aug; 219():112343. PubMed ID: 34020271
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 Prevents Oxidative Stress-Induced Astrocytic Senescence and Ameliorates Senescence Paracrine Effects on Glioblastoma.
Hou J; Kim S; Sung C; Choi C
Molecules; 2017 Sep; 22(9):. PubMed ID: 28891967
[TBL] [Abstract][Full Text] [Related]
12. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.
Freund A; Patil CK; Campisi J
EMBO J; 2011 Apr; 30(8):1536-48. PubMed ID: 21399611
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP).
Salminen A; Kauppinen A; Kaarniranta K
Cell Signal; 2012 Apr; 24(4):835-45. PubMed ID: 22182507
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel senomorphic agent, avenanthramide C, via the suppression of the senescence-associated secretory phenotype.
Lim JS; Lee DY; Kim HS; Park SC; Park JT; Kim HS; Oh WK; Cho KA
Mech Ageing Dev; 2020 Dec; 192():111355. PubMed ID: 32941937
[TBL] [Abstract][Full Text] [Related]
15. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
16. NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cells.
Raynard C; Ma X; Huna A; Tessier N; Massemin A; Zhu K; Flaman JM; Moulin F; Goehrig D; Medard JJ; Vindrieux D; Treilleux I; Hernandez-Vargas H; Ducreux S; Martin N; Bernard D
Aging Cell; 2022 Jul; 21(7):e13632. PubMed ID: 35653631
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype.
Wiley CD; Schaum N; Alimirah F; Lopez-Dominguez JA; Orjalo AV; Scott G; Desprez PY; Benz C; Davalos AR; Campisi J
Sci Rep; 2018 Feb; 8(1):2410. PubMed ID: 29402901
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8.
Bhaumik D; Scott GK; Schokrpur S; Patil CK; Orjalo AV; Rodier F; Lithgow GJ; Campisi J
Aging (Albany NY); 2009 Apr; 1(4):402-11. PubMed ID: 20148189
[TBL] [Abstract][Full Text] [Related]
19. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
Malaquin N; Tu V; Rodier F
Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
[TBL] [Abstract][Full Text] [Related]
20. CD36 initiates the secretory phenotype during the establishment of cellular senescence.
Chong M; Yin T; Chen R; Xiang H; Yuan L; Ding Y; Pan CC; Tang Z; Alexander PB; Li QJ; Wang XF
EMBO Rep; 2018 Jun; 19(6):. PubMed ID: 29777051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
